Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
New Senior Investment provides update amid COVID-19 pandemic » 07:40
06/18/20
06/18
07:40
06/18/20
07:40
SNR

New Senior Investment

$3.58 /

-0.21 (-5.54%)

The company said,…

The company said, "To date, our operators have reported a total of 172 positive cases across 25 properties (119 residents / 53 associates). As of June 16, our operators reported 13 current resident cases across 3 properties, representing less than 0.2% of our current resident population. 76% of the properties in our portfolio have had zero confirmed cases to date. Rate of new cases on a trailing three week average has declined 91% from peak levels in April. Over 1,200 residents and associates have been tested for COVID-19; 86% of those individuals have tested negative. Unclear how the rate of new cases will change as the pandemic continues and restrictions are lifted. Our operators are focused on safely lifting restrictions within our properties in a phased approach. Dependent on local mandates and the absence of any active or suspected COVID-19 positive cases within the community. As of June 16, over 90% of properties have begun lifting restrictions within the property. Over 30% of properties have moved to the second phase of recovery, which allows for expanded dining, activities, visitation and sales functions. Expect ongoing evaluation of the recovery phases as properties continue to lift restrictions. Since our last update (June 2), we have finalized May results and believe it is appropriate to update our view on 2Q20 NOI expectations in light of the actual results for May and the latest trends we are observing for June. 2Q20 results trending better than expected due to: i) less severe occupancy declines as the quarter progressed; ii) lower than expected COVID-19 expenses; and iii) lower than expected variable and fixed costs. As a result, 2Q20 NOI is currently trending closer to down 5% YoY, significantly better than initial estimate provided in May of down 10% to 15% YoY. Ultimate impact of the COVID-19 pandemic will depend on a variety of factors, and it remains too early to estimate the complete effects of the pandemic on the Company's results."

ShowHide Related Items >><<
SNR New Senior Investment
$3.58 /

-0.21 (-5.54%)

03/11/20 Mizuho
Sabra Health Care to be pressured by coronavirus at facility, says Mizuho
11/04/19 Capital One
New Senior Investment upgraded to Overweight from Equalweight at Capital One
10/22/19
Fly Intel: Top five analyst initiations
10/22/19 Capital One
New Senior Investment initiated with an Equalweight at Capital One
Over a quarter ago
Recommendations
Sabra Health Care to be pressured by coronavirus at facility, says Mizuho » 13:34
03/11/20
03/11
13:34
03/11/20
13:34
SBRA

Sabra Health Care

$14.16 /

-1.43 (-9.17%)

, VTR

Ventas

$39.23 /

-4.73 (-10.76%)

, WELL

Welltower

$57.34 /

-7.28 (-11.27%)

, OHI

Omega Healthcare

$32.22 /

-2.79 (-7.97%)

, CTRE

CareTrust REIT

$17.01 /

-2.66 (-13.52%)

, LTC

LTC Properties

$38.12 /

-2.18 (-5.41%)

, PEAK

Healthpeak

$29.74 /

-2.37 (-7.38%)

, DHC

Diversified Healthcare Trust

$4.78 /

-0.375 (-7.27%)

, SNR

New Senior Investment

$4.87 /

-0.52 (-9.65%)

Mizuho analyst Omotayo…

Mizuho analyst Omotayo Okusanya noted that Issaquah Nursing Home, which is owned by Sabra Health Care (SBRA), has confirmed the death of one of its residents from the coronavirus. Okusanya expects pressure on the stock given the coronavirus news, but said the news "feels priced in" with the stock down 10% today and down over 30% during the last two weeks. Other healthcare REITs with large skilled nursing and senior housing platforms include Ventas (VTR), Welltower (WELL), Omega Healthcare (OHI), CareTrust REIT (CTRE), LTC Properties (LTC), Healthpeak (PEAK), Diversified Healthcare Trust (DHC) and New Senior Investment (SNR), said the analyst. Okusanya keeps a Buy rating and $25 price target on Sabra shares.

ShowHide Related Items >><<
SBRA Sabra Health Care
$14.16 /

-1.43 (-9.17%)

02/26/20 Mizuho
Sabra Health Care upgraded to Buy from Neutral at Mizuho
02/05/20 Berenberg
Sabra Health Care initiated with a Hold at Berenberg
02/05/20 Berenberg
Sabra Health Care initiated with a Hold at Berenberg
01/07/20 Raymond James
Healthcare REIT sector downgraded to Market Weight at Raymond James
VTR Ventas
$39.23 /

-4.73 (-10.76%)

03/10/20 Jefferies
Jefferies downgrades Ventas, Welltower to Underperform on COVID-19 threat
03/10/20 Jefferies
Ventas downgraded to Underperform from Buy at Jefferies
02/28/20 Raymond James
Ventas upgraded to Market Perform from Underperform at Raymond James
01/22/20 Raymond James
Ventas 'pivot to growth' strategy to be delayed beyond 2021, says Raymond James
WELL Welltower
$57.34 /

-7.28 (-11.27%)

03/10/20 Jefferies
Welltower downgraded to Underperform from Hold at Jefferies
03/09/20 BMO Capital
Welltower downgraded to Market Perform from Outperform at BMO Capital
02/28/20 Raymond James
Welltower upgraded to Strong Buy from Market Perform at Raymond James
OHI Omega Healthcare
$32.22 /

-2.79 (-7.97%)

01/22/20
Fly Intel: Top five analyst initiations
01/22/20 Citi
Omega Healthcare initiated with a Neutral at Citi
12/19/19 Mizuho
Omega Healthcare initiated with a Buy at Mizuho
CTRE CareTrust REIT
$17.01 /

-2.66 (-13.52%)

02/28/20 Berenberg
CareTrust REIT downgraded to Hold from Buy at Berenberg
02/21/20 Stifel
CareTrust REIT reduced guidance brings buying opportunity, says Stifel
01/07/20 BMO Capital
CareTrust REIT downgraded to Market Perform from Outperform at BMO Capital
LTC LTC Properties
$38.12 /

-2.18 (-5.41%)

02/26/20 Berenberg
LTC Properties upgraded to Buy from Hold at Berenberg
12/19/19 Mizuho
LTC Properties assumed with a Neutral at Mizuho
12/10/19 Wells Fargo
LTC Properties downgraded to Underperform from Market Perform at Wells Fargo
12/10/19 Wells Fargo
LTC Properties downgraded to Underperform from Market Perform at Wells Fargo
PEAK Healthpeak
$29.74 /

-2.37 (-7.38%)

01/16/20
Ventas upgraded to Buy from Hold at Jefferies
12/19/19 Mizuho
Healthpeak initiated with a Buy at Mizuho
DHC Diversified Healthcare Trust
$4.78 /

-0.375 (-7.27%)

01/16/20 Wells Fargo
Diversified Healthcare Trust cut to Equal Weight from Overweight at Wells Fargo
01/07/20 Raymond James
Diversified Healthcare Trust upgraded to Market Perform from Underperform at Raymond James
01/07/20 Raymond James
Diversified Healthcare upgraded to Market Perform at Raymond James
SNR New Senior Investment
$4.87 /

-0.52 (-9.65%)

11/04/19 Capital One
New Senior Investment upgraded to Overweight from Equalweight at Capital One
10/22/19
Fly Intel: Top five analyst initiations
10/22/19 Capital One
New Senior Investment initiated with an Equalweight at Capital One
07/16/19 BTIG
New Senior Investment initiated with a Buy at BTIG
Upgrade
New Senior Investment upgraded to Overweight from Equalweight at Capital One » 05:23
11/04/19
11/04
05:23
11/04/19
05:23
SNR

New Senior Investment

$7.51 /

+0.48 (+6.83%)

Capital One analyst…

Capital One analyst Daniel Bernstein upgraded New Senior Investment Group to Overweight from Equalweight with an $8.50 price target.

ShowHide Related Items >><<
SNR New Senior Investment
$7.51 /

+0.48 (+6.83%)

10/22/19
Fly Intel: Top five analyst initiations
10/22/19 Capital One
New Senior Investment initiated with an Equalweight at Capital One
07/16/19 BTIG
New Senior Investment initiated with a Buy at BTIG
05/31/19 Baird
New Senior Investment initiated with a Neutral at Baird
Earnings
New Senior Investment narrows 2019 AFFO view to 64c-67c from 62c-67c » 06:17
11/01/19
11/01
06:17
11/01/19
06:17
SNR

New Senior Investment

$7.03 /

+0.04 (+0.57%)

Consensus for 2019 FFO is…

Consensus for 2019 FFO is 56c. Sees same store managed cash NOI: (3.0%)-0.0% vs. 2018.

ShowHide Related Items >><<
SNR New Senior Investment
$7.03 /

+0.04 (+0.57%)

10/22/19
Fly Intel: Top five analyst initiations
10/22/19 Capital One
New Senior Investment initiated with an Equalweight at Capital One
07/16/19 BTIG
New Senior Investment initiated with a Buy at BTIG
05/31/19 Baird
New Senior Investment initiated with a Neutral at Baird
Hot Stocks
New Senior Investment to sell Assisted Living/Memory Care portfolio for $385M » 06:15
11/01/19
11/01
06:15
11/01/19
06:15
SNR

New Senior Investment

$7.03 /

+0.04 (+0.57%)

New Senior Investment…

New Senior Investment announced that it has entered into a definitive purchase and sale agreement to sell its entire Assisted Living/Memory Care portfolio for a gross sale price of $385M. The company expects the Transaction to close in the first quarter of 2020, subject to customary closing conditions. The Transaction is expected to materially improve cash flow without a significant impact to AFFO. The AL/MC portfolio includes 28 properties across 14 states and consists of 2,840 units. The AL/MC portfolio is currently managed by six different operators and occupancy as of the third quarter was 78.0%. A key priority for New Senior has been to address the underperformance of its AL/MC portfolio. The company has pursued various strategies focused on improving performance, including asset sales and transitions to new operators. Despite these efforts, the AL/MC portfolio continued to experience sustained challenges. The Transaction is expected to improve the company's overall portfolio quality and capital structure, and will enable New Senior to focus on its core business - low acuity, private pay senior housing. Following the Transaction, the company's portfolio will consist of 102 Independent Living properties and 1 continuing care retirement community. The IL portfolio primarily serves the fast-growing middle market senior population, has delivered stable and consistent operating results, and is well positioned to benefit from medium and long-term demographic trends. Going forward, New Senior will continue to invest in attractive senior housing assets and partner with best-in-class operators to grow its core business. The gross sale price of $385M represents a 5.9% cap rate on third quarter 2019 trailing 12-month cash NOI or $136,000 per unit. The company expects to realize a gain on sale of approximately $27M prior to selling costs. Following the completion of the Transaction, New Senior's portfolio will consist of 103 properties, including 102 IL properties and 1 CCRC. The closing of the Transaction is expected to occur in the first quarter of 2020, subject to customary closing conditions.

ShowHide Related Items >><<
SNR New Senior Investment
$7.03 /

+0.04 (+0.57%)

10/22/19
Fly Intel: Top five analyst initiations
10/22/19 Capital One
New Senior Investment initiated with an Equalweight at Capital One
07/16/19 BTIG
New Senior Investment initiated with a Buy at BTIG
05/31/19 Baird
New Senior Investment initiated with a Neutral at Baird
Earnings
New Senior Investment reports Q3 adjusted FFO 17c, consensus 13c » 06:15
11/01/19
11/01
06:15
11/01/19
06:15
SNR

New Senior Investment

$7.03 /

+0.04 (+0.57%)

Reports Q3 revenue $,…

Reports Q3 revenue $, consensus $115.95M. Reports Q3 normalized FFO 14c. Q3 EPS was 34c, consensus (13c).

ShowHide Related Items >><<
SNR New Senior Investment
$7.03 /

+0.04 (+0.57%)

10/22/19
Fly Intel: Top five analyst initiations
10/22/19 Capital One
New Senior Investment initiated with an Equalweight at Capital One
07/16/19 BTIG
New Senior Investment initiated with a Buy at BTIG
05/31/19 Baird
New Senior Investment initiated with a Neutral at Baird
Initiation
Fly Intel: Top five analyst initiations » 10:21
10/22/19
10/22
10:21
10/22/19
10:21
AMCR

Amcor

$9.70 /

+0.015 (+0.15%)

, LEVI

Levi Strauss

$17.17 /

+0.16 (+0.94%)

, KTB

Kontoor Brands

$39.60 /

+0.49 (+1.25%)

, SNR

New Senior Investment

$7.05 /

+0.06 (+0.86%)

, BPMC

Blueprint Medicines

$78.39 /

-0.3 (-0.38%)

, SPXC

SPX Corporation

$41.29 /

-0.095 (-0.23%)

Catch up on today's…

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Amcor (AMCR) initiated with an Underperform at Jefferies. 2. Levi Strauss (LEVI) initiated with an Outperform at Macquarie while Kontoor Brands (KTB) was initiated with a Neutral. 3. New Senior Investment (SNR) initiated with an Equalweight at Capital One. 4. Blueprint Medicines (BPMC) resumed with an Outperform at JMP Securities. 5. SPX Corporation (SPXC) initiated with a Buy at Seaport Global. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
AMCR Amcor
$9.70 /

+0.015 (+0.15%)

10/22/19 Jefferies
Amcor initiated with an Underperform at Jefferies
06/20/19
Fly Intel: Top five analyst initiations
06/20/19 Citi
Citi starts Amcor with Bu rating, $13 price target
06/20/19 Citi
Amcor initiated with a Buy at Citi
LEVI Levi Strauss
$17.17 /

+0.16 (+0.94%)

10/21/19 Macquarie
Levi Strauss initiated with an Outperform at Macquarie
08/15/19
Fly Intel: Top five analyst upgrades
08/15/19 BofA
Levi Strauss upgraded to Buy at BofA/Merrill on valuation and brand momentum
08/15/19 BofA
Levi Strauss upgraded to Buy from Neutral at BofA/Merrill
KTB Kontoor Brands
$39.60 /

+0.49 (+1.25%)

10/21/19 Macquarie
Kontoor Brands initiated with a Neutral at Macquarie
06/17/19 Guggenheim
Kontoor Brands initiated with a Buy at Guggenheim
06/17/19 Piper Sandler
Kontoor Brands initiated with a Neutral at Piper Jaffray
06/13/19 Spin-Off Research
Kontoor Brands downgraded to Hold from Buy at Spin-Off Research
SNR New Senior Investment
$7.05 /

+0.06 (+0.86%)

10/22/19 Capital One
New Senior Investment initiated with an Equalweight at Capital One
07/16/19 BTIG
New Senior Investment initiated with a Buy at BTIG
05/31/19 Baird
New Senior Investment initiated with a Neutral at Baird
03/28/19 Morgan Stanley
Ventas initiated with an Equal Weight at Morgan Stanley
BPMC Blueprint Medicines
$78.39 /

-0.3 (-0.38%)

10/22/19 JMP Securities
Blueprint Medicines, Deciphera resumed with an Outperform at JMP Securities
10/22/19 JMP Securities
Blueprint Medicines resumed with an Outperform at JMP Securities
10/03/19 H.C. Wainwright
Blueprint Medicines initiated with a Buy at H.C. Wainwright
09/11/19 Raymond James
Blueprint Medicines upgraded to Outperform from Market Perform at Raymond James
SPXC SPX Corporation
$41.29 /

-0.095 (-0.23%)

10/22/19 Seaport Global
Seaport Global starts SPX Corporation at Buy with $50 price target
10/22/19 Seaport Global
SPX Corporation initiated with a Buy at Seaport Global
10/18/19 Sidoti
SPX Corporation initiated with a Buy at Sidoti
Initiation
New Senior Investment initiated with an Equalweight at Capital One » 06:14
10/22/19
10/22
06:14
10/22/19
06:14
SNR

New Senior Investment

$6.99 /

+0.02 (+0.29%)

Capital One initiated…

Capital One initiated coverage of New Senior Investment with an Equalweight rating and $7.50 price target.

ShowHide Related Items >><<
SNR New Senior Investment
$6.99 /

+0.02 (+0.29%)

07/16/19 BTIG
New Senior Investment initiated with a Buy at BTIG
05/31/19 Baird
New Senior Investment initiated with a Neutral at Baird
03/28/19 Morgan Stanley
Ventas initiated with an Equal Weight at Morgan Stanley
10/29/18 Morgan Stanley
New Senior Investment upgraded to Equal Weight at Morgan Stanley
Hot Stocks
New Senior Investment CFO David Smith resigns to accept another opportunity » 16:36
09/06/19
09/06
16:36
09/06/19
16:36
SNR

New Senior Investment

$6.28 /

-0.03 (-0.48%)

New Senior Investmen…

New Senior Investmen announced that David Smith has resigned as Executive Vice President and CFO to accept another business opportunity. Mr. Smith will continue in his current position through the third quarter to ensure a smooth transition for the company. Bhairav Patel, the company's current Executive Vice President of Finance & Accounting and Chief Accounting Officer will assume these additional responsibilities while the company conducts a search for a permanent replacement. Mr. Smith's resignation is not related to any issues involving the company's operations, financial statements, internal controls, policies or practices.

ShowHide Related Items >><<
SNR New Senior Investment
$6.28 /

-0.03 (-0.48%)

07/16/19 BTIG
New Senior Investment initiated with a Buy at BTIG
05/31/19 Baird
New Senior Investment initiated with a Neutral at Baird
03/28/19 Morgan Stanley
Ventas initiated with an Equal Weight at Morgan Stanley
10/29/18 Morgan Stanley
New Senior Investment upgraded to Equal Weight at Morgan Stanley
Earnings
New Senior Investment narrows 2019 AFFO view to 62c-67c from 61c-67c » 06:13
08/02/19
08/02
06:13
08/02/19
06:13
SNR

New Senior Investment

$7.09 /

-0.055 (-0.77%)

Consensus for 2019 FFO is…

Consensus for 2019 FFO is 58c.

ShowHide Related Items >><<
SNR New Senior Investment
$7.09 /

-0.055 (-0.77%)

07/16/19 BTIG
New Senior Investment initiated with a Buy at BTIG
05/31/19 Baird
New Senior Investment initiated with a Neutral at Baird
03/28/19 Morgan Stanley
Ventas initiated with an Equal Weight at Morgan Stanley
10/29/18 Morgan Stanley
New Senior Investment upgraded to Equal Weight at Morgan Stanley

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.